242142-71-8

Usage

Uses

Used in Pharmaceutical Industry:
(3β)-4,4-DiMethyl-cholesta-5,7,25-trien-3-ol is used as an intermediate in the preparation of follicular fluid-meiosis activating sterols (FF-MAS) for the pharmaceutical industry. These sterols are essential for the development and maturation of oocytes, playing a crucial role in the reproductive process. The compound's unique structure allows it to be a key component in the synthesis of these biologically active molecules, contributing to advancements in reproductive health and fertility treatments.
Used in Chemical Research:
As a member of the steroid family, (3β)-4,4-DiMethyl-cholesta-5,7,25-trien-3-ol is also used in chemical research for understanding the structure-activity relationships of various steroidal compounds. Its unique structural features make it an interesting subject for studying the effects of different functional groups on the biological activity of steroids. This research can lead to the development of new drugs with improved efficacy and selectivity.
Used in Cosmetics Industry:
Due to its steroidal nature, (3β)-4,4-DiMethyl-cholesta-5,7,25-trien-3-ol may also find applications in the cosmetics industry, where it could be used as an active ingredient in anti-aging and skin care products. Its potential to modulate cellular processes and its structural similarity to naturally occurring steroids in the human body make it a promising candidate for developing novel cosmetic formulations.

Upstream product

• 97344-88-2 isopentenylmagnesium bromide 
• 552302-71-3 (20S)-4,4-dimethyl-20-[((toluene-4-sulfonyl)oxy)methyl]-pregna-5,7-dien-3β-ol benzoate 
• 242142-70-7 (9S,10R,13R,14R,17R)-17-((R)-1,5-Dimethyl-hex-5-enyl)-4,4,10,13-tetramethyl-1,2,4,9,10,11,12,13,14,15,16,17-dodecahydro-cyclopenta[a]phenanthren-3-one 
• 40736-33-2 (20S)-20-hydroxymethylpregn-4-en-3-one 
• 242142-69-4 (9S,10R,13R,14R,17R)-17-((R)-1,5-Dimethyl-hex-5-enyl)-10,13-dimethyl-1,2,6,9,10,11,12,13,14,15,16,17-dodecahydro-cyclopenta[a]phenanthren-3-one 
• 592536-32-8 (20S)-4,4,20-trimethyl-pregna-5,7-dien-3β,21-diol benzoate 
• 356063-47-3 (20S)-20-[((triisopropylsilyl)oxy)methyl]-pregna-4-en-3-one 
• 462102-90-5 (8S,9S,10R,13S,14S,17R)-4,4,10,13-Tetramethyl-17-((S)-1-methyl-2-triisopropylsilanyloxy-ethyl)-1,2,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one 
• 552302-70-2 (20S)-4,4-dimethyl-20-[((triisopropylsilyl)oxy)methyl]-pregna-5-en-3β-ol benzoate 
• 841288-42-4 (20S)-4,4-dimethyl-20-[((triisopropylsilyl)oxy)methyl]-pregna-5,7-dien-3β-ol benzoate 
• 462102-91-6 (20S)-4,4-dimethyl-20-[((triisopropylsilyl)oxy)methyl]-pregna-5-en-3β-ol 

Downstream Products

• 64284-64-6 4,4-DIMETHYL-5ALPHA-CHOLESTA-8,14,24-TRIENE-3BETA-OL 

Relevant academic research and scientific papers

Two syntheses of FF-MAS

(Matrix presented) Follicular fluid-meiosis activating sterol (FF-MAS) has been shown to be an efficient inducer of meiotic maturation. It can potentially be used for improvements of in vitro fertilization techniques. Two short synthesis of FF-MAS are pre